1. A phase 1/2a study to test the safety and immunogenicity of a p16INK4a peptide vaccine in patients with advanced human papillomavirus‐associated cancers. Issue 9 (7th March 2016) Authors: Reuschenbach, Miriam; Pauligk, Claudia; Karbach, Julia; Rafiyan, Mohammad‐Reza; Kloor, Matthias; Prigge, Elena‐Sophie; Sauer, Madeleine; Al‐Batran, Salah‐Eddin; Kaufmann, Andreas M.; Schneider, Achim; Jäger, Elke; von Knebel Doeberitz, Magnus Journal: Cancer Issue: Volume 122:Issue 9(2016) Page Start: 1425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗